fluorobenzenes has been researched along with Experimental Spinal Cord Ischemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Die, J; Fan, L; Jiang, Y; Shi, Z; Wang, K | 1 |
1 other study(ies) available for fluorobenzenes and Experimental Spinal Cord Ischemia
Article | Year |
---|---|
Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.
Topics: Animals; Biomarkers; Blotting, Western; Fluorobenzenes; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; In Situ Nick-End Labeling; Infarction; Ischemic Preconditioning; Locomotion; Male; Mevalonic Acid; Neuroprotective Agents; Nitric Oxide Synthase; Pyrimidines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosuvastatin Calcium; Spinal Cord Ischemia; Sulfonamides; Treatment Outcome | 2010 |